(Q27139744)
English
alpha-Neup5Ac-(2->6)-[alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)]-D-GalpNAc
chemical compound
- alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[alpha-Neu5Ac-(2->6)]-D-GalNAc
- N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-D-glucosamine
- Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc
- alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)[alpha-Neup5Ac-(2->6)]-D-GalpNAc
- N-acetyl-alpha-neuraminyl-(2->6)-[N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)]-N-acetyl-D-glucosamine
- alpha-Neu5Ac-(2->6)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)]-D-GalNAc
Statements
965.334±0 dalton
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
C₃₆H₅₉N₃O₂₇
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)O)NC(=O)C)OC3C(C(C(C(O3)CO)O)OC4(CC(C(C(O4)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
CC(=O)N[C@@H]1[C@H](C[C@@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)OC[C@@H]2[C@@H]([C@@H]([C@H](C(O2)O)NC(=O)C)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@]4(C[C@@H]([C@H]([C@@H](O4)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)O)O
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
Identifiers
1 reference
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
2 references
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
1 reference
(6R)-5-Acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranonosyl-(2->6)-[(6R)-5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-beta-L-threo-hex-2-ulopyranono (English)
7 October 2016
2 references
Neu5Acalpha2-3Galbeta1-3(Neu5Acalpha2-6)GalNAc (English)
7 October 2016
2 references